Murphy CC, Tortolero GA, Gerber DE, Pruitt SL (2023) An updated report on the prevalence of prior cancer among persons newly diagnosed with cancer in the surveillance, epidemiology, and end results program. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2023.1723
Article PubMed PubMed Central Google Scholar
Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK (2013) Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol 10(5):289–301. https://doi.org/10.1038/nrclinonc.2013.41
Article PubMed CAS Google Scholar
Berrington de Gonzalez A, Curtis RE, Kry SF et al (2011) Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12(4):353–360. https://doi.org/10.1016/S1470-2045(11)70061-4
Travis LB, Ng AK, Allan JM et al (2014) Second malignant neoplasms and cardiovascular disease following radiotherapy. Health Phys 106(2):229–246. https://doi.org/10.1097/HP.0000000000000013
Article PubMed CAS Google Scholar
Ramin C, Veiga LHS, Vo JB, Curtis RE, Bodelon C, Aiello Bowles EJ, Buist DSM, Weinmann S, Feigelson HS, Gierach GL, Berrington de Gonzalez A (2023) Risk of second primary cancer among women in the Kaiser permanente breast cancer survivors cohort. Breast Cancer Res 25(1):50. https://doi.org/10.1186/s13058-023-01647-y
Article PubMed PubMed Central CAS Google Scholar
Sung H, Hyun N, Leach CR, Yabroff KR, Jemal A (2020) Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in the United States. JAMA 324(24):2521–2535. https://doi.org/10.1001/jama.2020.23130
Article PubMed PubMed Central Google Scholar
Phua ZJ, MacInnis RJ, Jayasekara H (2022) Cigarette smoking and risk of second primary cancer: a systematic review and meta-analysis. Cancer Epidemiol 78:102160. https://doi.org/10.1016/j.canep.2022.102160
Calip GS, Law EH, Ko NY (2015) Racial and ethnic differences in risk of second primary cancers among breast cancer survivors. Breast Cancer Res Treat 151(3):687–696. https://doi.org/10.1007/s10549-015-3439-7
Article PubMed PubMed Central Google Scholar
McGuire V, Lichtensztajn DY, Tao L, Yang J, Clarke CA, Wu AH, Wilkens L, Glaser SL, Park SL, Cheng I (2024) Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a surveillance, epidemiology, and end results (SEER) analysis. Cancer Causes Control 35(5):799–815. https://doi.org/10.1007/s10552-023-01836-2
Brandt C, Vo JB, Gierach GL, Cheng I, Torres VN, Lawrence WR, McCullough LE, Veiga LHS, Berrington de González A, Ramin C (2024) Second primary cancer risks according to race and ethnicity among US breast cancer survivors. Int J Cancer. https://doi.org/10.1002/ijc.34971
Ghanavati M, Khorshidi Y, Shadnoush M, Akbari ME, Ardehali SH, Chavarri-Guerra Y, Akbari A, Barragan-Carrillo R, Amin Amlashi M, Javid Z, Rahmani J (2023) Tamoxifen use and risk of endometrial cancer in breast cancer patients: a systematic review and dose-response meta-analysis. Cancer Rep 6(4):e1806. https://doi.org/10.1002/cnr2.1806
Fleming CA, Heneghan HM, O’Brien D, McCartan DP, McDermott EW, Prichard RS (2018) Meta-analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy. Br J Surg 105(9):1098–1106. https://doi.org/10.1002/bjs.10899
Article PubMed CAS Google Scholar
Godley LA, Larson RA (2008) Therapy-related myeloid leukemia. Semin Oncol 35(4):418–429. https://doi.org/10.1053/j.seminoncol.2008.04.012
Article PubMed PubMed Central CAS Google Scholar
Winer ES (2020) Secondary acute myeloid leukemia: a primary challenge of diagnosis and treatment. Hematol Oncol Clin North Am 34(2):449–463. https://doi.org/10.1016/j.hoc.2019.11.003
Morton LM, Dores GM, Schonfeld SJ, Linet MS, Sigel BS, Lam CJK, Tucker MA, Curtis RE (2019) Association of chemotherapy for solid tumors with development of therapy-related myelodysplastic syndrome or acute myeloid leukemia in the modern era. JAMA Oncol 5(3):318–325. https://doi.org/10.1001/jamaoncol.2018.5625
Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RE (2016) Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer 122(1):116–123. https://doi.org/10.1002/cncr.29685
Sung H, Siegel RL, Hyun N, Miller KD, Yabroff KR, Jemal A (2022) Subsequent primary cancer risk among 5-year survivors of adolescent and young adult cancers. J Natl Cancer Inst 114(8):1095–1108. https://doi.org/10.1093/jnci/djac091
Article PubMed PubMed Central Google Scholar
Chao C, Bhatia S, Xu L et al (2019) Incidence, risk factors, and mortality associated with second malignant neoplasms among survivors of adolescent and young adult cancer. JAMA Netw Open 2(6):e195536. https://doi.org/10.1001/jamanetworkopen.2019.5536
Article PubMed PubMed Central Google Scholar
Chen F, Park SL, Wilkens LR et al (2022) Genetic risk of second primary cancer in breast cancer survivors: the multiethnic cohort study. Cancer Res 82(18):3201–3208. https://doi.org/10.1158/0008-5472.CAN-21-4461
Article PubMed CAS Google Scholar
Wei JL, Jiang YZ, Shao ZM (2019) Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study. Int J Clin Oncol 24(8):934–940. https://doi.org/10.1007/s10147-019-01430-0
Berrington de Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M et al (2010) Second solid cancers after radiation therapy for breast cancer in SEER cancer registries. Br J Cancer 102(1):220e6. https://doi.org/10.1038/sj.bjc.6605435
Allen I, Hassan H, Joko-Fru WY, Huntley C, Loong L, Rahman T, Torr B, Bacon A, Knott C, Jose S, Vernon S, Lüchtenborg M, Pethick J, Lavelle K, McRonald F, Eccles D, Morris EJA, Hardy S, Turnbull C, Tischkowitz M, Antoniou AC (2024) Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study. Lancet Reg Health Eur 40:100903. https://doi.org/10.1016/j.lanepe.2024.100903
Article PubMed PubMed Central Google Scholar
Brantley KD, Rosenberg SM, Collins LC et al (2024) Second primary breast cancer in young breast cancer survivors. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2024.0286
Guzmán-Arocho YD, Rosenberg SM, Garber JE et al (2022) Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer. Br J Cancer 126(2):302–309. https://doi.org/10.1038/s41416-021-01597-2
Article PubMed CAS Google Scholar
Lauby-Secretan B, Scoccianti C, Loomis D et al (2016) Body fatness and cancer-viewpoint of the IARC working group. N Engl J Med 375(8):794–798. https://doi.org/10.1056/NEJMsr1606602
Article PubMed PubMed Central Google Scholar
U.S. Department of Health and Human Services (2020) Smoking Cessation. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
World Cancer Research Fund/American Institute for Cancer Research (2023) Continuous Update Project Expert Report 2018. Alcoholic drinks and the risk of cancer. wcrf.org. Accessed 23 August
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94(446):496–509. https://doi.org/10.1080/01621459.1999.10474144
Thom B, Friedman DN, Aviki EM et al (2023) The long-term financial experiences of adolescent and young adult cancer survivors. J Cancer Surviv 17(6):1813–1823. https://doi.org/10.1007/s11764-022-01280-2
Trama A, Tittarelli A, Barigelletti G et al (2022) Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: results from the first Italian population-based cohort. Cancer 128(2):364–372. https://doi.org/10.1002/cncr.33931
Comments (0)